Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glenmark Spins Out Innovation With New US Base

Executive Summary

Glenmark’s innovation business will now be housed in a spin-out arm, based in the US, where the Indian parent believes the ecosystem is more conducive to cutting-edge R&D. The new structure could also potentially provide new opportunities to unlock value for the parent company.
Advertisement

Related Content

Glenmark’s Coup: Gilead’s Riva Now CEO Of Spin-Out Innovation Firm
Deal Watch: Roivant Spins Out Arvelle, Licenses Epilepsy Candidate From SK Biopharma
Glenmark, Yuhan Partner for Ryaltris, Eyes On US Trajectory
Glenmark Re-Evaluates Complex Generics Basket, Won’t Be Part Of The 'Crowd'
Glenmark Spins Out Business To Drive Value
Ex-Sanofi Exec Stoeckli Primes Glenmark’s Cancer Therapy Ambitions

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC124673

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel